IE45427L - PYRROLO [3,2-f] QUINAZOLINE-1, 3-DIAMINE AND RELATED¹COMPOUNDS - Google Patents
PYRROLO [3,2-f] QUINAZOLINE-1, 3-DIAMINE AND RELATED¹COMPOUNDSInfo
- Publication number
- IE45427L IE45427L IE771345A IE134577A IE45427L IE 45427 L IE45427 L IE 45427L IE 771345 A IE771345 A IE 771345A IE 134577 A IE134577 A IE 134577A IE 45427 L IE45427 L IE 45427L
- Authority
- IE
- Ireland
- Prior art keywords
- methyl
- phenyl
- quinolinyl
- pyridinyl
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The present invention provides a compound if the general formula: or a non-toxic acid addition salt thereof, wherein: (a) X is hydrogen and Y is -CH2R or -R1 wherein: R is hydrogen; methyl; ethyl; n-propyl; i-propyl; n-butyl; i-butyl; n-pentyl; n-hexyl; 2-methyl-1-propenyl; cyclobutyl; cyclopentyl; cyclohexyl; 2-phenylethyl; 2-phenylvinyl; phenyl; phenyl monosubstituted in the 2-, 3-, or 4-position by chlorine, bromine, iodine, fluorine, trifluoromethyl, methyl, ethyl, n-propyl, i-prophyl, n-butyl, i-butyl, t-butyl, methoxy, ethoxy, n-propoxy, trifluoromethoxy, cyano, methylsulfonyl, acetyl, propionyl, methlthio, ethylthio, carbethoxy, carbonyl, sodium carboxy, or potassium carboxy; phenyl monsubstituted in the 3-position by amino or nitro; phenyl disubstituted in the 2,3-, 2,4-, 2,5-, 2,6-, 3,4-, or 3,5-positions by methyl, ethyl, n-propyl, methoxy, ethoxy, n-propoxy, chlorine, bromine, iodine, or fluorine; phenyl trisubstituted in the 2,4,6- or 3,4,5-positions by methyl, ethyl, methoxy, or ethoxy; 2,3,5,6tetramethylphenyl; 3,4-(methylene dioxy)phenyl; 1-naphthalenyl; 2-naphthalenyl; 2-methyl-1-naphthalenyl; 1-bromo-2-naphthalenyl; 2-pyridinyl; 3-pyridinyl; 4-pyridinyl; 2-quinolinyl; 8-quinolinyl; 2-thienyl; 3-thienyl; 4-thiazolyl; 3,5-dimethyl-4-isoxazolyl; tetrahydro-2-furanyl; or benzo(B)thein-3-yl; and R1 is hydrogen; phenyl monosubstituted in the 2- or 4position by amino, nitro, cyano, acetyl, propionyl, methylsulfonyl, trifluoromethyl or carbethoxy: 2,4-dinitrophenyl; 2,4-diamino-phenyl; 2-cyano-4-nitrophenyl; 2-cyano-4-aminophenyl; 3-methyl-4-nitrophenyl; 3-methyl-4-aminophenyl; 2-trifluoromethyl-4-nitro-phenyl; 2-trifluoromethyl-4-aminophenyl; 2-thiazolyl; 2-pyridinyl; 5-nitro-2-pyridinyl; 2-pyrimidinyl; 2-pyrazinyl; 2-quinolinyl; 4-quinolinyl, 4-methyl-2-quinolinyl; 7-chloro-4-quinolinyl; 7-trifluoromethyl-4-quinolinyl; 2-methyl-4-quinolinyl; 3methyl-2-quinoxalinyl; 2-phenyl-4-quinolinyl; or 2-benzothiazolyl; and (b) X is methyl, phenyl, or chlorine: and Y is hydrogen, methyl, benzyl, 3-cyanobenzyl, 4-cyanobenzyl, or 2,5-dimethylbenzyl; provided that when X is phenyl, Y may only be hydrogen or methyl, and when X is chlorine, Y may only be benzyl. The compounds inhibit the growth of bacteria in vitro as demonstrated in a standard tube dilution test employing seed agar or Wellcotest Sensitivity. In addition the compounds exhibit in vitro antifolic acid activity, as demonstrated by the inhibition of Streptoccus faecalis ATCC 8043 grown in a folic acid medium.
[CA1093555A]
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70400276A | 1976-07-09 | 1976-07-09 | |
US70400176A | 1976-07-09 | 1976-07-09 | |
GB5382176 | 1976-12-23 | ||
US78498777A | 1977-04-06 | 1977-04-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE45427L true IE45427L (en) | 1978-10-06 |
IE45427B1 IE45427B1 (en) | 1982-08-25 |
Family
ID=27449036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1345/77A IE45427B1 (en) | 1976-07-09 | 1977-06-29 | Pyrrold 3,2if quinazoline-1,3-diamine and related compounds |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS539796A (en) |
AU (1) | AU507828B2 (en) |
BE (1) | BE856647A (en) |
CA (1) | CA1093555A (en) |
CH (1) | CH634069A5 (en) |
DE (1) | DE2731039A1 (en) |
DK (1) | DK309977A (en) |
FR (1) | FR2357563A1 (en) |
IE (1) | IE45427B1 (en) |
IN (1) | IN147488B (en) |
MX (1) | MX5133E (en) |
NL (1) | NL7707658A (en) |
PH (1) | PH13539A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT99514B (en) * | 1990-11-14 | 1999-04-30 | Chiron Corp | PROCESS OF PREPARATION OF COMPOUNDS FOR THE TREATMENT OF FUNGIC INFECTIONS |
KR100810468B1 (en) * | 2001-10-10 | 2008-03-07 | 씨제이제일제당 (주) | 1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
US7262297B2 (en) * | 2003-05-15 | 2007-08-28 | Hoffmann-La Roche Inc. | Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
US11077109B2 (en) * | 2017-08-01 | 2021-08-03 | The Trustees Of Princeton University | Compounds having antibacterial activity and methods of use |
-
1977
- 1977-06-29 IE IE1345/77A patent/IE45427B1/en unknown
- 1977-07-01 AU AU26687/77A patent/AU507828B2/en not_active Expired
- 1977-07-04 CA CA281,981A patent/CA1093555A/en not_active Expired
- 1977-07-07 PH PH19967A patent/PH13539A/en unknown
- 1977-07-08 CH CH850677A patent/CH634069A5/en not_active IP Right Cessation
- 1977-07-08 NL NL7707658A patent/NL7707658A/en not_active Application Discontinuation
- 1977-07-08 DK DK309977A patent/DK309977A/en not_active Application Discontinuation
- 1977-07-08 BE BE179213A patent/BE856647A/en not_active IP Right Cessation
- 1977-07-08 DE DE19772731039 patent/DE2731039A1/en not_active Withdrawn
- 1977-07-08 MX MX775882U patent/MX5133E/en unknown
- 1977-07-08 FR FR7721232A patent/FR2357563A1/en active Granted
- 1977-07-09 JP JP8247077A patent/JPS539796A/en active Granted
- 1977-11-15 IN IN1610/CAL/77A patent/IN147488B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IN147488B (en) | 1980-03-15 |
IE45427B1 (en) | 1982-08-25 |
NL7707658A (en) | 1978-01-11 |
AU507828B2 (en) | 1980-02-28 |
JPS6254111B2 (en) | 1987-11-13 |
JPS539796A (en) | 1978-01-28 |
MX5133E (en) | 1983-03-28 |
CA1093555A (en) | 1981-01-13 |
CH634069A5 (en) | 1983-01-14 |
FR2357563B1 (en) | 1983-03-11 |
PH13539A (en) | 1980-06-26 |
DK309977A (en) | 1978-01-10 |
BE856647A (en) | 1978-01-09 |
DE2731039A1 (en) | 1978-01-19 |
FR2357563A1 (en) | 1978-02-03 |
AU2668777A (en) | 1979-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8202546A1 (en) | Thiazolidine derivatives and their production and use. | |
GB1461877A (en) | Assay method utilizing chemiluminescence | |
JPS5598189A (en) | Syn-isomer of 3, 7-di-substituted-3-cephem-4-carboxylic acid compound, its salt, and their preparation | |
GB1491510A (en) | 1-nitrophenylquinazoline-2,4(1h,3h)-diones | |
GB1133013A (en) | Process of preparing amides | |
GB1327312A (en) | Hererocyclic compounds | |
IE45427L (en) | PYRROLO [3,2-f] QUINAZOLINE-1, 3-DIAMINE AND RELATED¹COMPOUNDS | |
ES371709A1 (en) | Synthetic penicillins | |
IE45470L (en) | Thiophene derivatives | |
GB1160955A (en) | New Light-Developable Photographic Material and Recording Process | |
IE781618L (en) | Aminobenzoic acid derivatives | |
KR850001193A (en) | [(Pyridinyl) -2-pyrimidinyl] urea preparation method | |
GB1428990A (en) | Arylmercaptonaphtholactams | |
IE32013B1 (en) | A thiazolyl-acetamide derivative | |
GB1476073A (en) | Process for the preparation of hydroxyphenylacetonitriles | |
GB1358973A (en) | Acyloxy-phenylethanolamines | |
GB1139458A (en) | 2-phenylamino-2-oxazolines and their production | |
GB1363659A (en) | Tetralones and indanones | |
GB972964A (en) | A process for the manufacture of benzodiazepine derivatives | |
GB1367589A (en) | Isoindoline derivatives | |
IE40080B1 (en) | 2,5- or 2,6-disubstituted benzoxazoles | |
GB1174365A (en) | Benzotriazole Derivatives | |
GB1511475A (en) | Hydrazinopyridazine derivatives having antihypertensive activity | |
GB888598A (en) | Diazotype material | |
ES8601891A1 (en) | 1,4-Dihydropyridine compound. |